Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Hayashida

Showing results (241-250 of 374) with videos related to

Pageof 38
Sort By:
BMJ Open|June 12, 2021
Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registryFumiaki Yashima, Masahiko Hara, Taku Inohara, et al.
Journal of the American Heart Association|September 17, 2021
Prognostic Value of Ventricular-Arterial Coupling After Transcatheter Aortic Valve Replacement on Midterm Clinical OutcomesHiroaki Yokoyama, Futoshi Yamanaka, Koki Shishido, et al.
The American Journal of Cardiology|October 3, 2017
Predictors of 1-Year Mortality After Transcatheter Aortic Valve Implantation in Patients With and Without Advanced Chronic Kidney DiseaseAmos Levi, Pablo Codner, Amer Masalha, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2021
Balloon Post-Dilatation Improves Long-Term Valve Performance After Balloon-Expandable Valve ImplantationYugo Nara, Yusuke Watanabe, Akihisa Kataoka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 19, 2024
Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices - Insight From the OCEAN-LAAC RegistryMasaki Nakashima, Masanori Yamamoto, Mitsuru Sago, et al.
ESC Heart Failure|April 12, 2024
Long-term prognostic value of the H<sub>2</sub>FPEF score in patients undergoing transcatheter aortic valve implantationKenichi Ishizu, Shinichi Shirai, Akihiro Isotani, et al.
The Canadian Journal of Cardiology|May 30, 2020
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ReplacementMizuki Miura, Kyohei Yamaji, Shinichi Shirai, et al.
The American Journal of Cardiology|August 4, 2018
Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve ImplantationRyo Yanagisawa, Makoto Tanaka, Fumiaki Yashima, et al.
JACC. Cardiovascular Interventions|November 1, 2020
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVRHideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, et al.
BMJ Open|August 20, 2018
Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in JapanKazuki Mizutani, Masahiko Hara, Mana Nakao, et al.
Pageof 38

Showing results (241-250 of 374) with videos related to

Sort By:
Pageof 38
BMJ Open|June 12, 2021
Statin therapy for patients with aortic stenosis who underwent transcatheter aortic valve implantation: a report from a Japanese multicentre registryFumiaki Yashima, Masahiko Hara, Taku Inohara, et al.
Journal of the American Heart Association|September 17, 2021
Prognostic Value of Ventricular-Arterial Coupling After Transcatheter Aortic Valve Replacement on Midterm Clinical OutcomesHiroaki Yokoyama, Futoshi Yamanaka, Koki Shishido, et al.
The American Journal of Cardiology|October 3, 2017
Predictors of 1-Year Mortality After Transcatheter Aortic Valve Implantation in Patients With and Without Advanced Chronic Kidney DiseaseAmos Levi, Pablo Codner, Amer Masalha, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2021
Balloon Post-Dilatation Improves Long-Term Valve Performance After Balloon-Expandable Valve ImplantationYugo Nara, Yusuke Watanabe, Akihisa Kataoka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 19, 2024
Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices - Insight From the OCEAN-LAAC RegistryMasaki Nakashima, Masanori Yamamoto, Mitsuru Sago, et al.
ESC Heart Failure|April 12, 2024
Long-term prognostic value of the H<sub>2</sub>FPEF score in patients undergoing transcatheter aortic valve implantationKenichi Ishizu, Shinichi Shirai, Akihiro Isotani, et al.
The Canadian Journal of Cardiology|May 30, 2020
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ReplacementMizuki Miura, Kyohei Yamaji, Shinichi Shirai, et al.
The American Journal of Cardiology|August 4, 2018
Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve ImplantationRyo Yanagisawa, Makoto Tanaka, Fumiaki Yashima, et al.
JACC. Cardiovascular Interventions|November 1, 2020
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVRHideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, et al.
BMJ Open|August 20, 2018
Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in JapanKazuki Mizutani, Masahiko Hara, Mana Nakao, et al.
Pageof 38